Showing results (81-90 of 100) with videos related to
Sort By:
Pageof 10
American Journal of Clinical Oncology|February 1, 2011
Results of the 2005 to 2008 Association of Residents in Radiation Oncology surveys of chief residents in the United States: didactics and research experienceVinai Gondi, Johnny Ray Bernard, Siavash Jabbari, et al.Journal of Neurosurgery|March 30, 2010
A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiformeLinna Li, Tony S Quang, Ed J Gracely, et al.Plos One|February 7, 2015
Micheliolide derivative DMAMCL inhibits glioma cell growth in vitro and in vivoYinghong An, Wanjun Guo, Linna Li, et al.International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Results of the 2005-2008 Association of Residents in Radiation Oncology survey of chief residents in the United States: clinical training and resident working conditionsVinai Gondi, Johnny Ray Bernard, Siavash Jabbari, et al.Bioorganic & Medicinal Chemistry|May 31, 2016
Synthesis, biological evaluation, and physicochemical property assessment of 4-substituted 2-phenylaminoquinazolines as Mer tyrosine kinase inhibitorsSheng-Biao Wang, Mu-Tian Cui, Xiao-Feng Wang, et al.Journal of Medicinal Chemistry|June 28, 2017
In Vivo and Mechanistic Studies on Antitumor Lead 7-Methoxy-4-(2-methylquinazolin-4-yl)-3,4-dihydroquinoxalin-2(1H)-one and Its Modification as a Novel Class of Tubulin-Binding Tumor-Vascular Disrupting AgentsMu-Tian Cui, Li Jiang, Masuo Goto, et al.American Journal of Clinical Oncology|November 11, 2010
Increased recurrences using intensity-modulated radiation therapy in the postoperative settingAruna Turaka, Tianyu Li, Navesh K Sharma, et al.International Journal of Radiation Oncology, Biology, Physics|January 7, 2019
Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Brachytherapy Applicators Is Feasible and Safe: First Results From the TRIUMPH-T TrialAtif J Khan, Peter Y Chen, Catheryn Yashar, et al.Clinical and Translational Science|June 25, 2026
Drug Interactions of Vebreltinib, a Novel Type I c-Met Inhibitor, Coadministration With Rifampin or Itraconazole in Healthy ParticipantsJingcheng Chen, Jingxuan Wu, Yuqin Song, et al.Nano Letters|June 5, 2023
Fe Single Atom Catalysts Promoting Polysulfide Redox Reduction in Quantum Dot PhotovoltaicsLinna Li, Yu Lin, Yongming Xia, et al.Pageof 10